A landmark clinical trial is testing whether we can reprogram aging eye cells back to health — opening a door that medicine has never opened before. By Arthur Benjamin, MD. Founder & Medical Director, Benjamin Eye Institute
Dr. Arthur Benjamin: The Gene Therapy That Could Reverse Blindness
